Jul 2026· Journal of Chemical Information and Modeling· Vol 66, pp. 7900 - 7916· 0 citations· 31 references
Medicine
TL;DR
These findings suggest that pretraining directly on notation that makes structural constraints explicit offers a transferable strategy for biomolecular modalities that fall between small-molecule chemistry and protein sequence.
Abstract
Chemically modified and macrocyclic peptides are increasingly important therapeutics, yet current molecular representation models do not natively represent chemical modification and covalent topology in a unified way. Atom-level strings obscure macrocyclic connectivity, whereas protein sequence models cannot encode noncanonical residues and explicit cross-links. Here we pretrain an encoder-only transformer directly on Hierarchical Editing Language for Macromolecules (HELM) notation, which specifies monomer identity and connectivity. In this work, we show that the resulting representations achieve best mean performance in cyclic peptide membrane permeability prediction (random split R 2 = 0.668; retaining best mean performance under a Murcko scaffold split), exceeding external pretrained SMILES-based encoders. An architecture-matched SMILES control narrowed the HELM–SMILES gap under full finetuning, whereas HELM-BERT retained clearer advantages in frozen-representation settings. HELM-BERT also preserves HELM-specified macrocyclic topology in a linearly accessible form and supports competitive peptide–protein interaction prediction across complementary Propedia and ChEMBL benchmarks. More broadly, these findings suggest that pretraining directly on notation that makes structural constraints explicit offers a transferable strategy for biomolecular modalities that fall between small-molecule chemistry and protein sequence.
Vilya-1 is introduced, a deep learning model that addresses two central challenges in macrocycle design: sampling biologically relevant conformations across arbitrary chemistries and predicting key developability properties such as membrane permeability.
Vilya Research Pascal Sturmfels, M. Salem, Naozumi Hiranuma et al.· arXiv.org· 1 citation
Vilya-2 is the structure-prediction oracle that de novo peptide design pipelines require--establishing the all-atom approach as a general foundation for the design and evaluation of de novo peptide therapeutics.
Pascal Sturmfels, Naozumi Hiranuma, Milad Salem et al.· arXiv.org· 0 citations
OmniScore is introduced, a universal structure-based framework that learns a shared geometry-aware representation of complexes once and then adapts it to downstream scoring through lightweight task-specific heads, suggesting that geometry-aware pretraining can provide a reusable scoring backbone for tasks that depend o...
HighPlay2 is presented as a feasible framework for the early-stage design and screening of cyclic peptide candidates containing ncAAs, while further affinity maturation and experimental structural validation remain necessary.
Huitian Lin, Wentong Wang, Ning Zhu et al.· European journal of medicina...· 0 citations
HighMorph is presented, an interaction-guided framework that combines protein–protein interaction information with artificial intelligence for rational cyclic peptide design and provides insights for developing therapeutics targeting challenging protein interfaces.
M. Lan, Cheng-Yun Zhang, Wentong Wang et al.· Journal of Medicinal Chemist...· 0 citations
It is argued that the convergence of geometric logic with automated synthesis and AI‑driven design will transform peptidomimetics into a primary modality for decoding and therapeutically engaging the human interactome, including historically "undruggable" PPIs.
Jesang Lee, Sumin Son, J. Y. Yoo et al.· Angewandte Chemie· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.